Thermo Fisher Scientific Inc. (TMO)

NYSE: TMO · USD

$565

-9.30 (-1.6%)· Recorded snapshot

Coverage state: Latest published research available

Market snapshot recorded 2026-08-05 02:00 UTC. Latest published research analyzed 2026-05-09 · historical · sources unverified. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate a fresh TMO analysis

The published report stays available while a new owner-requested analysis runs.

StockMarketAgent Research · Analyzed 2026-05-09

Our latest published analysis: TMO rated Hold

TMO is rated Hold at $474.46 versus the reconciled fair value midpoint of $500.89, implying +5.57% upside/downside. Confidence is separately disclosed at 88/100.

Fair value (mid)

$501 / share

$384 – $619

Upside to FV

+5.6%

from $565

Confidence

88/100

Moat

9/10

Read full analysis

Market cap	$176.3B
Revenue (ttm)	46.3B
Net income (ttm)	7B
EPS (ttm)	$18.6
Shares out	369.7M
P/E (trailing)	30.4x
P/E (forward)	17.3x
Dividend	$1.88 (0.33%)
Volume	1,941,856
Beta	0.85
Price target	$628	+11.1%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 46.3B
Net income (ttm): 7B
EPS (ttm): $18.6
P/E (trailing): 30.4x
P/E (forward): 17.3x
Market cap: $176.3B

Item	P1	P2	P3	P4	P5	Trend
Period	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31	Trend
Revenue	$39.21B	$44.92B	$42.86B	$42.88B	—	+2.3%
Gross profit	$19.64B	$18.97B	$17.10B	$17.70B	—	-2.6%
Operating income	$10.23B	$8.51B	$7.32B	$7.72B	—	-6.8%
Net income	$7.73B	$6.95B	$6.00B	$6.34B	—	-4.8%
EPS (diluted)	—	$17.63	$15.45	$16.53	$17.74	+0.2%
EBITDA	$11.97B	$11.94B	$11.08B	$11.54B	—	-0.9%
R&D	$1.41B	$1.47B	$1.34B	$1.39B	—	-0.3%
SG&A	$8.01B	$8.99B	$8.45B	$8.60B	—	+1.8%

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
AAPL	Apple Inc.	4.6T	35.9x	9.8x	101.6%	+6.1%	+47.5%	Sell
ABNB	Airbnb Inc.	105B	40.3x	8.0x	16.8%	+24.4%	+36.5%	Hold
ADBE	Adobe Inc.	105.4B	15.2x	4.2x	60.7%	+11.9%	-23.3%	Strong Buy
ABBV	AbbVie Inc.	434.8B	69.5x	6.8x	17.7%	+3.7%	+29.2%	Hold
ABT	Abbott Laboratories	186.6B	34.9x	4.0x	7.5%	+3.0%	-15.8%	Strong Buy
AMGN	Amgen Inc.	222.2B	25.5x	5.8x	19.8%	+8.4%	+48.7%	Strong Buy

All TMO indicators

Market & fundamental data

Available fields

292

Groups with data

Currency

USD

Showing 292 of 292 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000097745
Company name	Thermo Fisher Scientific Inc.
Country	United States
Country code	US
Cusip	883556102
Employees	125,000
Employees Change	3,000%
Employees Change Percent	2.46
Enterprise value	$247.3B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
In Index	SP500
Industry	Diagnostics & Research
Industry PE	43.87
Industry PE Fwd	26.16
Isin	US8835561023
Last refreshed	2026-08-05
Market cap	$208.8B
Market cap category	Mega-Cap
Price	$565
Price currency	USD
Rev Per Employee	370,688x
Sector	Healthcare
Sector PE	46.02
Sector PE Fwd	22.82
Sic	3829
Symbol	TMO
Website	https://www.thermofisher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.34%
EV Earnings	35.5x
EV Sales Forward	5.04x
EV/EBIT	30.36x
EV/EBITDA	22.3x
EV/FCF	33.79x
EV/Sales	5.34x
FCF yield	3.5%
Forward P/E	21.51x
P/B ratio	3.96x
P/E ratio	30.39x
P/S ratio	4.51x
PE Ratio10 Y	31.48x
PE Ratio3 Y	31.04x
PE Ratio5 Y	31.18x
PEG ratio	2.38x
PS Forward	4.26x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	17.58%
EBITDA Margin	23.93%
FCF margin	15.79%
Gross margin	40.99%
Gross Profit	$19B
Gross Profit Growth	6.41%
Gross Profit Growth Q	11.11%
Gross Profit Growth3 Y	3.04%
Gross Profit Growth5 Y	-0.66%
Net Income	$7B
Net Income Growth	5.82%
Net Income Growth Q	7.36%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	6.79%
Net Income Growth5 Y	-4.12%
Pretax Margin	16.37%
Profit Margin	15.04%
Profit Per Employee	$55,736
Profitable Quarters	$98
Profitable Years	24
ROA	5.13
Roa5y	5.62
ROCE	8.3
ROE	13.52
Roe5y	15.21
ROIC	8.84
Roic5y	10.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.06%
Cagr15y	17.01%
Cagr1y	22.43%
Cagr20y	14.81%
Cagr3y	1.31%
Cagr5y	1.3%
Div CAGR10	11.86%
Div CAGR3	10.87%
Div CAGR5	12.97%
EPS Growth	7.45
EPS Growth Q	9.39
EPS Growth Quarters	7
EPS Growth Years	2
EPS Growth3 Y	8.28
EPS Growth5 Y	-2.96
FCF Growth	18.61%
FCF Growth Q	51.58%
FCF Growth3 Y	7.72%
FCF Growth5 Y	-2.09%
OCF Growth	18.94%
OCF Growth Q	51.89%
OCF Growth10 Y	10.84%
OCF Growth3 Y	5.42%
OCF Growth5 Y	-2.54%
Revenue Growth	7.23x
Revenue Growth Q	10.49x
Revenue Growth Quarters	8x
Revenue Growth Years	2x
Revenue Growth3 Y	2.11x
Revenue Growth5 Y	3.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.43
Assets	$113.2B
Cash	$4.1B
Current Assets	$23.4B
Current Liabilities	$15.1B
Debt	$42.5B
Debt EBITDA	$3.84
Debt Equity	$0.81
Debt FCF	$5.81
Equity	$52.8B
Interest Coverage	5.55
Liabilities	$60.4B
Long Term Assets	$89.8B
Long Term Liabilities	$45.3B
Net Cash	$-38.5B
Net Cash By Market Cap	$-18.43
Net Debt EBITDA	$3.47
Net Debt Equity	$0.73
Net Debt FCF	$5.26
Tangible Book Value	$-20.8B
Tangible Book Value Per Share	$-56.14
WACC	7.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.55
Inventory Turnover	4.89
Net Working Capital	$7.6B
Quick ratio	1.01
Working Capital	$8.3B
Working Capital Turnover	$4.6

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.44%
Dividend Growth	9.52%
Dividend Growth Years	8%
Dividend per share	$1.88
Dividend Years	15
Dividend Yield	0.33%
Ex Div Date	2026-09-15
Last Dividend	$0.47
Payout Frequency	Quarterly
Payout Ratio	10.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	272.51%
1Y total return	22.41%
200-day SMA	531.1
3Y total return	3.98%
50-day SMA	509.6
50-day SMA vs 200-day SMA	50under200
5Y total return	6.65%
All Time High	672.3
All Time High Change	-16%
All Time High Date	2021-12-31
All Time Low	1
All Time Low Change	56,454.18%
All Time Low Date	1982-08-11
ATR	17.26
Beta	0.85
Beta1y	0.75
Beta2y	0.7
Ch YTD	-2.54
High	582.3
High52	644
High52 Date	2026-01-22
High52ch	-12.3%
Low	562.5
Low52	435.3
Low52 Date	2026-05-18
Low52ch	29.75%
Ma50ch	10.83%
Premarket Change Percent	-0.06
Premarket Price	$574
Premarket Volume	780
Price vs 200-day SMA	6.33%
RSI	62.38
RSI Monthly	54.99
RSI Weekly	59.81
Sharpe ratio	0.68x
Sortino ratio	1.29
Total Return	1.78%
Tr YTD	-2.34
Tr15y	955.15%
Tr1m	7.89%
Tr1w	-2.02%
Tr3m	20.48%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	28
Analyst Count Top	14
Analyst Price Target Top	$608
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$5.71
Earnings EPS Estimate Growth	6.53
Earnings Revenue Estimate	11,697,028,392x
Earnings Revenue Estimate Growth	7.76x
Operating Income	$8.8B
Operating Income Growth	10.65
Operating Income Growth Q	15.51
Operating Income Growth3 Y	6.55
Operating Income Growth5 Y	-4.05
Operating margin	18.99
Price target	$628
Price Target Change	$11.13
Price Target Change Top	$7.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	368,792,996%
Float Percent	99.74%
Net Borrowing	7,958,000,000
Shares Insiders	0.13%
Shares Institutions	92.35%
Shares Out	369,747,286
Shares Qo Q	-0.54%
Shares Yo Y	-1.45%
Short Float	1.44%
Short Ratio	2.52
Short Shares	1.43

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$7B
Adjusted OCF	8,694,000,000
Average Volume	2,206,731.2x
Bv Per Share	142.5
CAPEX	$-1.7B
Ch10y	262
Ch15y	897.3
Ch1m	7.89
Ch1w	-2.02
Ch1y	21.97
Ch20y	1,397.2
Ch3m	20.36
Ch3y	2.99
Ch5y	5.17
Ch6m	-0.94
Change	-1.62%
Change From Open	-2.42
Close	574
Days Gap	0.82
Depreciation Amortization	2,942,000,000
Dollar Volume	1,096,663,176
Earnings Date	2026-07-23
Earnings Time	bmo
EBIT	$8.1B
EBITDA	$11.1B
EPS	$18.58
F Score	4
FCF	$7.3B
FCF EV Yield	2.96x
FCF Per Share	$19.79
Financing CF	2,416,000,000
Fiscal Year End	December
Founded	1,956
Goodwill	54,832,000,000
Graham Number	244.07084
Graham Upside	-56.78
Income Tax	$598M
Investing CF	-12,029,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-07-23
Last Report Date	2026-06-27
Last Split Date	1996-06-06
Last Split Type	Forward
Last10k Filing Date	2026-02-26
Lynch Fair Value	$92.92
Lynch Upside	-83.55
Ma150	517.6
Ma150ch	9.11%
Ma20	547.7
Ma20ch	3.11%
Net CF	-507,000,000
Next Earnings Date	2026-10-21
Open	578.8
Optionable	Yes
P FCF Ratio	28.53
P FCF Ratio SBC	29.83
P OCF Ratio	23.17
P OCF Ratio SBC	24.02
Payment Date	2026-10-15
Position In Range	11.36
Post Close	564.8
Postmarket Change Percent	-0.01
Postmarket Price	$565
Ppne	10,755,000,000
Pre Close	574
Price Date	2026-08-04
Price EBITDA	$18.83
Relative Volume	0.88x
Revenue	46,336,000,000x
SBC By Revenue	0.69x
Share Based Comp	319,000,000
Tax By Revenue	1.29x
Tax Rate	7.88%
Tr20y	1,484.13%
Tr6m	-0.74%
Us State	Massachusetts
Volume	1,941,856
Z Score	3.44

Frequently asked questions

About this TMO report

What is the latest published TMO stock rating?

Thermo Fisher Scientific Inc. is shown with hold in the latest published report, analyzed 2026-05-09. The hub links directly to the full analysis surface where the dated rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TMO analysis?

The full latest published report, analyzed 2026-05-09, lives at /stocks/TMO/analysis. The bare ticker page summarizes that read and links to each analysis tab; earlier editions remain under /analysis/archive.

What fair-value range is used for TMO?

The latest published report analyzed 2026-05-09 frames TMO around USD 384 to USD 619. This is a dated valuation range, not a live market price; check the valuation, sensitivity, and bear-case tabs before making a decision.

How often is the TMO page updated?

The hub selects the latest published stock report regardless of age and displays its analysis date (2026-05-09). Separately sourced market data is labeled with its own recorded timestamp and is never inferred from the report.

Thermo Fisher Scientific Inc. (TMO)

Coverage state: Latest published research available

Generate a fresh TMO analysis

Our latest published analysis: TMO rated Hold

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TMO

Valuation

Profitability

Balance sheet

Trading

Position sizing & entry playbook

Next earnings

Sector percentile context

All TMO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TMO

Frequently asked questions